Clinical Trials Sponsored by Mipharm SpA

Total 3497 results

Zambon SpA

Completed

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

Idiopathic Parkinson Disease

Spain, Austria, Italy, Germany, France
Zambon SpA

Completed

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Respiratory Tract Diseases | Abnormal Mucus Secretions

China
SIFI SpA

Completed

Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome (ProGIFT)

Dry Eye Disease

Italy
SIFI SpA

Completed

A Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® (047/SI)

Dry Eye Syndromes

France, Spain
Zambon SpA

Completed

Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Asthma

United Kingdom
Zambon SpA

Completed

Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)

no Condition
Zambon SpA

Completed

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers

Respiratory Tract Disorders

China
Cassiopea SpA

Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

Acne Vulgaris

United States, Bulgaria, Georgia, Poland, Romania, Serbia
Cassiopea SpA

Completed

An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris

Acne Vulgaris

United States, Poland
VISUfarma SpA

Unknown

Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED

Dry Eye Syndromes

France, Italy, Spain
Zambon SpA

Withdrawn

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Parkinson Disease | Dyskinesia, Drug-Induced
Sintetica SA
Cross S.A.

Completed

Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia

Phase 1: Pain Management | Phase 2: Pain Management

Switzerland
AMIpharm Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area

Healthy

Korea, Republic of
AMIpharm Co., Ltd.

Completed

Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

Moderate or Severe Submental Fullness

Korea, Republic of
TRPHARM

Active, not recruiting

Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA)

Bronchiectasis | Pulmonary Disease | Adenosine Deaminase Deficiency

Turkey
AMIpharm Co., Ltd.

Completed

Evaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy Subjects

Healthy Subjects | Submental Fat

Korea, Republic of
AMIpharm Co., Ltd.

Completed

Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat (AYP-101)

Moderate or Severe Submental Fullness

Korea, Republic of
TRPHARM

Enrolling by invitation

Investigation of ADA Enzyme Deficiency

Adenosine Deaminase Deficiency

Turkey
TRPHARM

Enrolling by invitation

Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E

Adenosine Deaminase Deficiency

Turkey
TRPHARM

Withdrawn

Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator

Healthy
TRPHARM

Enrolling by invitation

Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar Proteinosis

Pulmonary Alveolar Proteinosis

Turkey
Read-Gene S.A.
National Center for Research and Development, Poland; IQ Pharma S.A.; West Pomeranian... and other collaborators

Active, not recruiting

Prevention of Female Cancers by Optimization of Selenium Levels in the Organism. (SELINA)

Breast Neoplasms

Poland
Sintetica SA
Cross Research S.A.

Terminated

Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section

Unplanned Caesarean Section

Belgium
Sintetica SA
Cross Research S.A.

Completed

Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures

Pain, Postoperative

Switzerland
Montefarmaco OTC SpA

Recruiting

An Interventional, Confirmative, Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients. (M-GLAU-01-2020)

Opthalomology/Dry Eye

Italy
Heinz Italia SpA

Recruiting

Potential Protective Effect of a Formula Supplemented With Fermented Matrices on the Risk of Developing Neonatal Sepsis

Neonatal Sepsis

Italy
Newron Pharmaceuticals SPA

Terminated

Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms (STARS)

Rett Syndrome

United States, India, United Kingdom, Australia, Italy
BetaGlue Technologies spa

Completed

Prevention of PNX and Haemorrhagic Complications in Diagnostic Percutaneous Lung Biopsy Using the MIPP-Kit Device (MIPP-PNX1)

Complications in Diagnostic Percutaneous Lung Biopsy Procedures

Italy
Newron Pharmaceuticals SPA

Terminated

Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients

Parkinson's Disease

Romania
Newron Pharmaceuticals SPA

Terminated

A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging

Parkinson Disease

United States
Newron Pharmaceuticals SPA

Completed

A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Chronic Schizophrenia

United States, India
Newron Pharmaceuticals SPA

Completed

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist (MOTION)

Idiopathic Parkinson's Disease

United States, Spain, Brazil, Peru, Colombia, Germany, Argentina, India, Croatia, Czech Republic, Italy, South Africa, Finland, Portugal, Canada, Slovakia, Bulgaria, Chile, Mexico, Poland
Newron Pharmaceuticals SPA

Completed

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects (Safinamide-LID)

Parkinson's Disease

Austria, Canada, France, Germany, South Africa
Newron Pharmaceuticals SPA

Terminated

MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918) (MOTION)

Idiopathic Parkinson's Disease

Switzerland
Newron Pharmaceuticals SPA

Completed

Safinamide Renal Impairment Trial

Renal Impairment

Germany
Newron Pharmaceuticals SPA

Completed

A Study to Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics

Hepatic Impairment

Germany
Newron Pharmaceuticals SPA

Completed

Phase II Dose Titration Study in Patients With Neuropathic Pain

Neuropathic Pain

United Kingdom, Czech Republic, Poland, Italy, India, Austria
Algenis SpA
Oncoclínicas

Recruiting

Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy

Brazil
Newron Pharmaceuticals SPA

Completed

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Schizophrenia

India, United States
Montefarmaco OTC SpA

Completed

Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia

Hypercholesterolemia

Italy
Heinz Italia SpA

Completed

Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS)

Nutritional Safety

Italy
Heinz Italia SpA

Unknown

Oat Products in the Treatment of Coeliac Disease in Children

Clinical and Nutritional Safety.

Italy
Newron Pharmaceuticals SPA

Completed

A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease

Parkinson's Disease With Cognitive Impairments

Spain, United States
Newron Pharmaceuticals SPA

Completed

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)

Parkinson's Disease
Sintetica SA
Cross Research S.A.

Not yet recruiting

Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population

Local Anesthetic
Montefarmaco OTC SpA

Recruiting

A Post-market Study to Evaluate the Effects of Sodium Hyaluronate Based Eye Drops in Patients Affected by Dry Eye Disease (M-DED-2020)

Opthalomology/Dry Eye

Italy
Welcare Industries SpA

Recruiting

Clinical Trial to Evaluate Safety and Efficacy of Jalosome® Soothing Gel. (JALOSOME-01)

Radiation-induced Dermatitis

Italy
Farmaceutici Damor Spa

Recruiting

Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze (FP)

Wounds and Injuries | Wound Infection | Wound Heal

Italy
Lipogems International spa

Recruiting

A Single Intra-articular Injection of aMAT vs PRP in Patients With OA of the Knee (LIPOJOINT)

Osteoarthritis, Knee

Italy
VISUfarma SpA
CROlife

Completed

VISUPRIME® Eye Drops

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Macular Degeneration, Age Related | Myopic Choroidal Neovascularisation | Macular Edema of Right Retina (Diagnosis)

Italy

3

Subscribe